24 Apr, 2023 09:55 AM
MELBOURNE, AUSTRALIA 24 April 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treatme...read more
31 Jan, 2023 09:02 AM
MELBOURNE, AUSTRALIA 31 January 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treat...read more
17 Jan, 2023 09:47 AM
The securities of Arovella Therapeutics Limited (‘ALA’) will be placed in trading halt at the request of ALA, pending it releasing an announcement. Unless ASX decides otherwise, the secu...read more